ConductScience.org, home

Paper10024596

Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.

Mansouri E and 9 others. Infect Immun, 1999. Cited by 67 papers, by iCite.

Cite this record

ConductScience Library. Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers. Papers, record 10024596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10024596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
PubMed
Journal
Infect Immun
PubMed
Year
1999
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
67
iCite
Relative citation ratio, by iCite
1.95
iCite
Revised in PubMed
2020-07-24
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mansouri EE
2Gabelsberger JJ
3Knapp BB
4Hundt EE
5Lenz UU
6Hungerer KDK D
7Gilleland HE JrH E
8Staczek JJ
9Domdey HH
10von Specht BUB U

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial ProteinsMajor topic
Bacterial VaccinesMajor topic
LipoproteinsMajor topic
PorinsMajor topic
Pseudomonas aeruginosaMajor topic
Recombinant Fusion ProteinsMajor topic
Vaccines, SyntheticMajor topic
Adult
Antibodies, Bacterial
Female
Humans
Male
Phagocytosis
Vaccination

Source PubMed

Download CSV of topics

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13131471Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.J Lab Clin Med1988https://conductscience.org/library/papers/3131471PubMed
21730152Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3.Clin Immunol Immunopathol1992https://conductscience.org/library/papers/1730152PubMed
37729895
Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.
Infect Immun1995https://conductscience.org/library/papers/7729895PubMed
491774Controlled trials of a polyvalent pseudomonas vaccine in burns.Lancet1979https://conductscience.org/library/papers/91774PubMed
59437483Nosocomial infections in an oncology intensive care unit.Am J Infect Control1997https://conductscience.org/library/papers/9437483PubMed
62602775Pseudomonas bacteremia in a community teaching hospital, 1980-1984.Rev Infect Dis1989https://conductscience.org/library/papers/2602775PubMed
78063415Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine.Infect Immun1994https://conductscience.org/library/papers/8063415PubMed
89456102Secular trends in nosocomial bloodstream infections in a 55-bed cardiothoracic intensive care unit.Ann Thorac Surg1998https://conductscience.org/library/papers/9456102PubMed
99673254Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains.Infect Immun1998https://conductscience.org/library/papers/9673254PubMed
103102446Intrinsic antibiotic resistance of Pseudomonas aeruginosa.J Antimicrob Chemother1986https://conductscience.org/library/papers/3102446PubMed
118911006Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers.Vaccine1996https://conductscience.org/library/papers/8911006PubMed
129571743High incidence of antibiotic resistance among bacteria in 4 intensive care units at a university hospital in Sweden.Scand J Infect Dis1997https://conductscience.org/library/papers/9571743PubMed
132733597Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.Microb Pathog1989https://conductscience.org/library/papers/2733597PubMed
142210853Nosocomial infections in general surgery: surveillance report from a German university clinic.Infection1990https://conductscience.org/library/papers/2210853PubMed
152449095Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.Anal Biochem1987https://conductscience.org/library/papers/2449095PubMed
1611000453Immunogenic efficacy of differently produced recombinant vaccines candidates against Pseudomonas aeruginosa infections.J Biotechnol2000https://conductscience.org/library/papers/11000453PubMed
172511252The epidemiology of Pseudomonas aeruginosa in oncology patients in a general hospital.J Infect Dis1989https://conductscience.org/library/papers/2511252PubMed
181438580Molecular and cellular basis of immune protection of mucosal surfaces.Physiol Rev1992https://conductscience.org/library/papers/1438580PubMed
197839727
Protection of immunosuppressed mice against translocation of Pseudomonas aeruginosa from the gut by oral immunization with recombinant Pseudomonas aeruginosa outer membrane protein I expressing Salmonella dublin.
Vaccine1994https://conductscience.org/library/papers/7839727PubMed
20402473A new polyvalent Pseudomonas vaccine.J Med Microbiol1977https://conductscience.org/library/papers/402473PubMed

See all 49 referencesDownload CSV of references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.

PMIDTitleJournalYearIn PapersSource
42750463Targeting Outer Membrane Vesicles of Pseudomonas aeruginosa: From Pathogenesis to Therapeutics.J Microbiol Biotechnol2026https://conductscience.org/library/papers/42750463PubMed
41599011Taming Superbugs: Current Progress and Challenges in Combating ESKAPE Pathogens.Pathogens2025https://conductscience.org/library/papers/41599011PubMed
41498839Bibliometric analysis of Pseudomonas aeruginosa vaccine development highlighting research status, evolution, and future opportunities.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41498839PubMed
40076637Pseudomonas aeruginosa Vaccine Development: Lessons, Challenges, and Future Innovations.Int J Mol Sci2025https://conductscience.org/library/papers/40076637PubMed
37515079The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria.Vaccines (Basel)2023https://conductscience.org/library/papers/37515079PubMed
36258075Pseudomonas aeruginosa Antivirulence Strategies: Targeting the Type III Secretion System.Adv Exp Med Biol2022https://conductscience.org/library/papers/36258075PubMed
36069593Multicomponent Pseudomonas aeruginosa Vaccines Eliciting Th17 Cells and Functional Antibody Responses Confer Enhanced Protection against Experimental Acute Pneumonia in Mice.Infect Immun2022https://conductscience.org/library/papers/36069593PubMed
35891262Pseudomonas aeruginosa: Recent Advances in Vaccine Development.Vaccines (Basel)2022https://conductscience.org/library/papers/35891262PubMed
33972378Cell-free expression of the outer membrane protein OprF of Pseudomonas aeruginosa for vaccine purposes.Life Sci Alliance2021https://conductscience.org/library/papers/33972378PubMed
33291484Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine.Cells2020https://conductscience.org/library/papers/33291484PubMed
32131866Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial.Crit Care2020https://conductscience.org/library/papers/32131866PubMed
30814874Recombinant outer membrane protein Q and putative lipoprotein from Bordetella pertussis inducing strong humoral response were not protective alone in the murine lung colonization model.Turk J Biol2018https://conductscience.org/library/papers/30814874PubMed
30314911PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia.Vaccine2018https://conductscience.org/library/papers/30314911PubMed
30008053Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy.Virus Genes2018https://conductscience.org/library/papers/30008053PubMed
28159015A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients.Crit Care2017https://conductscience.org/library/papers/28159015PubMed
26855594Pseudomonas aeruginosa ventilator-associated pneumonia management.Infect Drug Resist2016https://conductscience.org/library/papers/26855594PubMed
25964476Identification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosa.Infect Immun2015https://conductscience.org/library/papers/25964476PubMed
24575895Vaccines for Pseudomonas aeruginosa: a long and winding road.Expert Rev Vaccines2014https://conductscience.org/library/papers/24575895PubMed
24064511A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers.Hum Vaccin Immunother2014https://conductscience.org/library/papers/24064511PubMed
23607394RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF.Clin Exp Immunol2013https://conductscience.org/library/papers/23607394PubMed

See all 31 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
C1QA712PubTator's text mininghttps://conductscience.org/library/genes/712

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10024596

GET https://conductscience.org/api/papers/v1/10024596/references?page=2